Software P Pharmaceutical Executive
Pathos Ai Enters Drug Development Collaboration with Bristol Myers Squibb and Tempus Ai
Pathos AI launches multi-year collaborations to build an AI-driven dataset for Alzheimer’s and other neurological diseases.
The latest biotech and pharma news from the trade press, updated every hour and linked straight to the publisher. Follow funding, clinical, deals and more. Every story links straight to its publisher.
Software P Pharmaceutical Executive
Pathos AI launches multi-year collaborations to build an AI-driven dataset for Alzheimer’s and other neurological diseases.
Industry B BioPharm International
Anurag Rathore, PhD, professor of chemical engineering at IIT Delhi, explains how his team cuts monoclonal antibody costs without cutting purification steps, and why the $10-per-gram target could make antibodies viable for infectious disease and global access.
Industry B BioPharm International
Anurag Rathore, PhD, professor of chemical engineering at IIT Delhi, explains how his team is making antibody manufacturing more efficient and replacing costly raw materials to cut monoclonal antibody costs to about $10 per gram.
Industry P pharmaphorum
ESMO26: AZ's claudin ADC doubles survival in GI cancers Phil.Taylor Mon, 26/10/2026 - 13:30
Industry P Pharmaceutical Commerce
At LogiPharma USA 2026, Cold Chain Technologies' Vijay Paliwal discusses reusable shippers, PCM innovation and AI's role in cold chain risk.
Industry P Practical Fragments
Last week we highlighted an example of adding a warhead to a fragment-derived, non-covalent protein binder to generate a covalent inhibitor. This is probably the most common method for identifying covalent ligands. But as we noted in 2019, the reverse “covalent-first” approach ca…
Agriculture
CropLife
GROWMARK backs new domestic fertilizer production, strengthening supply reliability and supporting farmers across the Eastern Corn Belt. The post GROWMARK Invests in Wabash Valley Resources’ Indiana Ammonia Fertilizer Project appeared first on CropLife.
Industry
Inside Precision Medicine
To improve in vitro fertilization and fertility treatments, UC San Francisco and Conceivable Life Sciences have created a robotics, AI, and personalized embryology research center. The post When Sperm Meets Egg, Meet the Robots: UCSF and Conceivable Automate IVF appeared first on…
Industry
PharmaVoice
After helping launch a blockbuster Roche and Genentech therapy, Erik Lundgren is betting that Immunic's experimental drug can address persistent gaps in MS care, with pivotal trial results approaching
Industry P pharmaphorum
Cardiovascular disease today: NMR-based lipoprotein profiling Nicole.Raleigh Mon, 26/10/2026 - 12:22
Funding P pharmaphorum
UK biotech financing shoots up, setting up "a record year" Phil.Taylor Mon, 26/10/2026 - 11:56
Industry
Clinical Trials Arena
Clinical Trials Arena brings you the lung cancer highlights from ESMO 2026, with readouts from MSD, AstraZeneca, Roche and BioNTech. The post ESMO26: Key data breathing new life into the lung cancer field appeared first on Clinical Trials Arena.
Manufacturing
Pharmaceutical Technology
When it’s time to look for a fill-finish CDMO, the transition to GMP filling is not just a scale issue — it’s a regulatory, technical, and operational shift.
Regulatory
MedCity News
[Sponsored] For US biotech companies developing rare disease therapies, decisions about clinical evidence, patient populations and regulatory advice can have consequences in Europe long before a marketing application is submitted. The post FDA Alignment Is a Starting Point, Not a…
Industry P Pharmafile
Nuclera, the biotechnology company enabling access to innovative protein technologies, has appointed Carl Raimond as Chief Executive Officer, effective immediately. Dr Michael Chen, the company’s co-founder and former CEO, becomes Chief Scientific and Business Officer, “continuin…
Software M Matt Gamber
Value creating catalysts for ****, ****, ****, ****, ****, ****, ****, ****, ****, and ****.
Clinical
Clinical Trials Arena
The data presented at IDWeek is from the Phase II portion of the Platform Trial for Cryptococcal Meningitis (PLATFORM-CM). The post IDWeek 2026: novel antifungal turletricin demonstrates positive Phase II results appeared first on Clinical Trials Arena.
Regulatory P pharmaphorum
ESMO26: Roche's KRAS drug tops approved drugs in NSCLC Phil.Taylor Mon, 26/10/2026 - 10:54
Industry
Clinical Trials Arena
Given the urgent need for an orally administered, safer alternative to AmB, olorofim has strong potential to receive FDA approval for IA in 2027. The post IDWeek 2026: olorofim shows promise in second-line invasive aspergillosis appeared first on Clinical Trials Arena.
Industry
Clinical Trials Arena
Bayer’s Nubeqa is already well established in prostate cancer, but DASL-HiCaP data broadens potential patient populations. The post ESMO26: Combination therapies show promise in prostate cancer appeared first on Clinical Trials Arena.
Funding
European Biotechnology
Denmark's Genmab has reported that its antibody-drug conjugate rinatabart sesutecan (Rina-S) reduced the risk of progression or death by 71% and the risk of death by 57%, compared with conventional chemotherapy in a 584-patient Phase 3 trial of platinum-resistant ovarian cancer.…
Industry P pharmaphorum
31st Edition Strategic Project & Portfolio Management for Pharma Nicole.Raleigh Mon, 26/10/2026 - 10:08
Clinical
Clinical Trials Arena
Alnylam Pharmaceuticals has reported preliminary results from an ongoing Phase Ib clinical study assessing its investigational RNAi candidate, brezosiran, in adult patients with HD. The post Alnylam reports preliminary Phase Ib trial results for brezosiran appeared first on Clini…
Industry
Pharmaceutical Technology
Lunit and Summit Therapeutics have entered a research agreement to assess the Lunit SCOPE IO AI pathology platform for analysing the tumour microenvironment across immuno-oncology programmes evaluating ivonescimab.
Industry P Pharmaceutical Executive
Pharmaceutical and health economist Dr. Nadine Zawadzki, Senior Director, FTI Consulting joins the Ron Lanton Report to discuss how value is defined and measured across healthcare.
Industry P Pharmaceutical Executive
Shionogi’s Dr. Draica on why COVID-19 still matters — and why the window between exposure and symptoms is where XOCOVA can intervene.
Industry B BioPharm International
Pharmaceutical and health economist Dr. Nadine Zawadzki, Senior Director, FTI Consulting joins the Ron Lanton Report to discuss how value is defined and measured across healthcare.
Software P Pharmaceutical Executive
Brox.AI’s Hamish Brocklebank on why it retired “digital twin” for “digital clone” — and why the distinction matters for pharma research accuracy.
Clinical
Clinical Trials Arena
Pfizer has reported data from a Phase II trial assessing PF-07872412, its investigational 25-valent pneumococcal conjugate vaccine candidate, in infants. The post Pfizer reports Phase II data for 25vPnC infant vaccine candidate appeared first on Clinical Trials Arena.
Research B BioTechniques
Original story from ETH Zurich (Switzerland). Many biological molecules are short-lived and ephemeral. Now, researchers have developed an archive function that allows them to look into a cell’s past for the first time. Information on what a cell did a few hours or days ago is gen…
Funding
Pharmaceutical Technology
Pathos AI has secured $237m in a Series E round to expand its clinical oncology pipeline and scale its AI drug development platform.
Industry
Clinical Trials Arena
While there has been a shift to new modalities in “hot” cancers, chemotherapy has remained steadfast in the first line for “cold” tumours – but this is changing, say experts at ESMO26. The post ESMO26: Novel combo successes signal shift from frontline chemo in cold cancers appear…
Industry
MedTech Dive
The proposed acquisition of the specialty laboratory is the third Labcorp buyout announced in eight days.
Industry
BioPharma Dive
Some overlooked medicines aren’t failures. They just arrived before the market was ready.
Industry
BioPharma Dive
Explore manufacturing challenges and solutions for ADCs, bispecifics, peptides and more.
Manufacturing
MedTech Dive
For medical device manufacturers, reshoring has been discussed for years. Now, many are putting it into action and hitting familiar capacity challenges along the way.
Industry
PharmaVoice
What is bioprocess observability? See how real-time monitoring improves process control.
Clinical P Pharmafile
Most patients with advanced hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer are treated in community settings rather than academic centres, potentially limiting their access to clinical trials, according to an analysis by Phesi. The company analysed 47,011 pati…
Industry
STAT Biotech
Moderna's CEO Stéphane Bancel on what's next after the recent success in cancer vaccine, and how that impacts the company's business strategy.
Manufacturing P pharmaphorum
UK puts £100m into "world-first" AI biosecurity facility Phil.Taylor Mon, 26/10/2026 - 07:52